期刊文献+

比卡鲁胺治疗前列腺癌的临床应用 被引量:4

Clinical application of bicalutamide in the treatment of prostate cancer
下载PDF
导出
摘要 比卡鲁胺是一种新型的非甾体抗雄激素药物,内分泌治疗是前列腺癌治疗的主要手段。本文就比卡鲁胺单药治疗前列腺癌、联合化疗治疗前列腺癌及联合放疗或去势手术治疗前列腺癌的临床疗效作一综述。 Bicalutamide is a non-steroidal anti-androgen drug. Endocrine therapy is the primary approach for the treatment of prostate cancer. This article introduces the clinical efficacy of bicalutamide monotherapy,in combination with chemotherapy,radiotherapy or orchiectomy in the treatment of prostate cancer.
出处 《上海医药》 CAS 2014年第11期58-60,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 比卡鲁胺 前列腺癌 临床疗效 bicalutamide prostate cancer clinical efifcacy
  • 相关文献

参考文献9

二级参考文献67

  • 1华立新,吴宏飞,眭元庚,徐正铨,张炜,钱立新,居小兵,张杰秀.比卡鲁胺治疗激素抵抗性前列腺癌[J].中华泌尿外科杂志,2005,26(6):383-385. 被引量:9
  • 2叶定伟.前列腺癌的流行病学和中国的发病趋势[J].中华外科杂志,2006,44(6):362-364. 被引量:168
  • 3夏术阶,主译.前列腺癌[M].北京:人民卫生出版社,2004:161-78.
  • 4Prostate Cancer Trialists' Collaborative Group. Maximum androgen blockade in advanced prostate cancer. An overview of the randomised trials. Lancet, 2000, 355: 1491-1498.
  • 5Schellhammer PF, Sharifir R, Block NL, et al. Clinical benefits of Bicalutamide compared with Flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Urology, 1997, 50: 330-336.
  • 6Kolvenbag GJ, Blackledge GR, Gotting-Smith K. Bicalutamide (Casodex) in the treatment of prostate cancer: history of clinical development. Prostate, 1998, 34: 61-72.
  • 7Iversen P, Tyrrell CJ, Kaisary AV. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6. 3 years of followup. J Urol, 2000, 164: 1579-1582.
  • 8Wirth MP, See WA, McLeod DG, et al. Bicalutamide 150mg in addition to standard care in patients with localized or locally advanced prostate cancer: results form the second analysis of the early prostate cancer program at median follow up of 5.4 years. J Urol, 2004, 172: 1865-1870.
  • 9Nelson JB. Hormone therapy for prostate cancer//Wein AI, Kavoussi LR, Novick AC, et al. Compbell-Walsh urology. 9th ed. Philadephia: Saunders Elsevier, 2007: 3082-3100.
  • 10Denis LJ, Keuppens F, Smith PH, et al. Maximal androgen blockade: Final analysis of EORTC phase I trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and EORTC Data Center. Eur Urol, 1998, 33: 144-151.

共引文献30

同被引文献36

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部